₹3671.7
0.84%
Low
Day's Volatility:1.90%
High
1.07%
16.90%
Low
52 Weeks Volatility:27.87%
High
10.97%
Returns % | |
1 Month Return | 7.59 % |
3 Month Return | 0.41 % |
1 Year Return | 10.96 % |
Market Stats | |
Previous Close | ₹3,708.90 |
Open | ₹3,661.00 |
Volume | 7.46L |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹98,459.64Cr |
based on 24 analysts
Based on 24 analysts offering long term price targets for Divis Laboratories Ltd. An average target of ₹3462.92
Source: S&P Global Market Intelligence
Organisation | Divis Laboratories Ltd |
Headquarters | Hyderabad |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Divis Laboratories Ltd
Despite declining earnings, Divis Laboratories Ltd's high P/E ratio of 71.2x is due to analysts predicting strong future growth. Shareholders are confident in the company's future earnings.
Analysts Upgrade Divis Labs Rating and Target Price - 04 Apr, 2024
Divis Laboratories Ltd sees positive momentum as DRChoksey initiates coverage with an 'Accumulate' rating, while BofA Securities upgrades it to Buy from Underperform with a revised target price of Rs 4,025. The stock has gained for five consecutive sessions.
Divis Labs Upgraded by BofA Securities - 03 Apr, 2024
Global brokerage BofA Securities upgraded Divis Laboratories to buy from underperform and raised the target price to Rs 4,025 apiece due to its improving earnings outlook. KR Chokseys initiated coverage on the stock with an accumulate rating and a target price of Rs 3,931. The pharma company reported a Q3 FY24 net profit of Rs 358 crore, up 17% YoY.
Divis Laboratories Ltd Up 1.51% on NSE - 02 Apr, 2024
Divis Laboratories Ltd is up 1.51% on the NSE, trading at Rs 3622 as of 12:49 IST. The stock has gained 26% in the last year compared to a 28.88% gain in NIFTY and a 58.71% gain in the Nifty Pharma index.
Divis Labs to Build New Factory in Andhra Pradesh - 01 Apr, 2024
Divis Laboratories is investing ₹1,200-1,500 crore in the first phase of building a new factory over 500 acres in Kona, Kakinada. The company reported revenues of ₹7,974 crore in FY23.
Divis Laboratories Insiders Sell Significant Stake - 26 Mar, 2024
Over the past year, Divis Laboratories insiders have sold a significant stake in the company. In the last three months alone, insiders sold ₹302m worth of shares without any purchases recorded. While high insider ownership is good, the selling leaves investors cautious.
Fundamentals of Divis Laboratories Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
Netprofit is up for the last 2 quarters, 348.0 Cr → 358.0 Cr (in ₹), with an average increase of 2.8% per quarter
MF Holding Up
Mutual Funds have increased holdings from 13.62% to 13.72% in Dec 2023 quarter
FII Holding Up
Foreign Institutions have increased holdings from 14.60% to 14.86% in Dec 2023 quarter
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 136.7% return, outperforming this stock by 139.3%
Against Peers
In the last 1 year, Sun Pharmaceuticals Industries Ltd has given 52.3% return, outperforming this stock by 41.4%
Promoter Holding Down
Promoters have decreased holdings from 51.93% to 51.92% in Dec 2023 quarter
Price Dip
In the last 3 years, DIVISLAB stock has moved down by -2.6%
Revenue Fall
Revenue is down for the last 2 quarters, 1.99K Cr → 1.95K Cr (in ₹), with an average decrease of 2.3% per quarter
Retail Holding Down
Retail Investor have decreased holdings from 11.72% to 11.33% in Dec 2023 quarter
Divis Laboratories Ltd in the last 5 years
Lowest (28.97x)
November 21, 2022
Industry (61.24x)
April 18, 2024
Today (71.17x)
April 18, 2024
Highest (78.53x)
December 28, 2023
Funds | Holdings |
SBI Equity Hybrid Fund Direct Growth | 3.54% |
SBI Focused Equity Fund Direct Plan Growth | 4.28% |
Axis ELSS Tax Saver Fund Direct Plan Growth Option | 2.78% |
SBI Bluechip Fund Direct Growth | 2.1% |
SBI Multicap Fund Direct Growth | 3.01% |
Investors | Holdings % | Prev. 4 periods | 3M change |
---|---|---|---|
Promoter Holdings | 51.92% | ||
Foreign Institutions | 14.86% | 1.79 | |
Mutual Funds | 13.72% | 0.75 | |
Retail Investors | 11.33% | ||
Others | 8.17% | 0.42 |
Technicals of Divis Laboratories Ltd share
News & Events of Divis Laboratories Ltd
News
A total of 2,668 shares changed hands on the counter till 12:13PM (IST)
16 Apr, 2024 12:13 PMManish Dubey, chief marketing officer, Pidilite Industries, talks to BrandWagon Online about the conceptualisation, thought and more about the campaign
17 Apr, 2024 08:00 AMA total of 5,329 shares changed hands on the counter till 01:28PM (IST)
19 Apr, 2024 01:28 PMDivis Laboratories Ltd (DIVISLAB) share price today is ₹3671.7
Divis Laboratories Ltd is listed on NSE
Divis Laboratories Ltd is listed on BSE
PE Ratio of Divis Laboratories Ltd is 71.17
PE ratio = Divis Laboratories Ltd Market price per share / Divis Laboratories Ltd Earnings per share
Today’s traded volume of Divis Laboratories Ltd(DIVISLAB) is 7.46L.
Today’s market capitalisation of Divis Laboratories Ltd(DIVISLAB) is ₹98459.64Cr.
Divis Laboratories Ltd(DIVISLAB | Price |
---|---|
52 Week High | ₹4074.4 |
52 Week Low | ₹3051 |
Divis Laboratories Ltd(DIVISLAB) share price is ₹3671.7. It is down -9.88% from its 52 Week High price of ₹4074.4
Divis Laboratories Ltd(DIVISLAB) share price is ₹3671.7. It is up 20.34% from its 52 Week Low price of ₹3051
Divis Laboratories Ltd(DIVISLAB | Returns |
---|---|
1 Day Returns | -37.2% |
1 Month Returns | 7.59% |
3 Month Returns | 0.41% |
1 Year Returns | 10.96% |